Hostname: page-component-848d4c4894-sjtt6 Total loading time: 0 Render date: 2024-06-14T02:26:36.996Z Has data issue: false hasContentIssue false
  • English
  • Français

The Need for Vigilance in Identifying Those at Risk from Drug-induced Headache

Published online by Cambridge University Press:  06 October 2014

Michael R. Forsyth  and
Paul R. Martin
Michael R. Forsyth
Affiliation:
The University of New England
Paul R. Martin
Affiliation:
The University of New England
Get access

Extract

A case study is described to illustrate the need for vigilance in detecting drug-induced headache. A woman (“Jane”) volunteered for a headache research program, and assessment revealed a very high consumption of headache medication. Jane was taking an average of 21 tablets per day as well as receiving injections several times a week. The research staff directed her to record her medication, and to take these records to her doctor for review. Two general practitioners and a psychiatrist responded that there was no need for intervention, but the researchers were sufficiently concerned that they encouraged her to find another doctor. The fourth doctor admitted her to hospital immediately for detoxification with spectacularly beneficial results.

Type
Research Article
Information
Behaviour Change , Volume 14 , Issue 4 , December 1997 , pp. 227 - 229
Copyright
Copyright © The Author(s) 1997

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Baumgartner, C., Wessely, P., Bignol, C., Maly, J., & Holzner, F. (1989). Long-term prognosis of analgesic withdrawal in patients with drug-induced headaches. Headache, 29, 510–514.CrossRefGoogle ScholarPubMed
DeLeon, P.M., Fox, R.E., & Graham, S.R. (1991). Prescription privileges: Psychology's next frontier? American Psychologist, 46, 384–393.CrossRefGoogle ScholarPubMed
Elseviers, M.M., & Debroe, M.E. (1996a). Combination analgesic involvement in the pathogenesis of analgesic nephropath: The European perspective. American Journal of Kidney Diseases, 28(1 Suppl. 1), S 48–S.CrossRefGoogle Scholar
Elseviers, M.M., & Debroe, M.E. (1996b). A long-term prospective controlled study of analgesic abuse in Belgium. Kidney International, 48(6), 1912–1919.CrossRefGoogle Scholar
Headache Classification Committee of the International Headache Society. (1988). Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia, 8(Suppl.), 9–96.Google Scholar
Lanas, A.I., Remacha, B., Esteva, F., & Sainz, R. (1995). Risk factors associated with refractory peptic ulcers. Gastroenterology, 109(4), 1124–1133.CrossRefGoogle ScholarPubMed
Martin, P.R. (1993). Psychological management of chronic headaches. New York: Guilford.Google Scholar
Martin, P.R. (in press). Headache. In Johnston, M. & Johnston, D. (Eds.), Health psychology. Oxford: Elsevier Science.Google Scholar
Nanra, R.S. (1993). Analgesic nephropathy in the 1990s: An Australian perspective. Kidney International, 44(Suppl. 42), S86–S92.Google Scholar
Saper, J.R. (1987). Ergotamine dependency: A review. Headache, 27, 435–438.CrossRefGoogle ScholarPubMed
Wisotzky, J., Bosseckert, H., Jansa, U., & Stein, G. (1996). Pancreatic alterations in chronic nephritis with and without abuse of analgesics. Nieren-und Hochdruckkrankheiten, 25(2), 82–86.Google Scholar